QQQ   432.22 (+0.27%)
AAPL   169.35 (-1.93%)
MSFT   416.39 (+0.66%)
META   502.86 (+0.53%)
GOOGL   154.69 (-0.11%)
AMZN   184.02 (+0.22%)
TSLA   157.92 (-2.20%)
NVDA   875.30 (+1.78%)
AMD   163.71 (+2.11%)
NIO   3.84 (-1.29%)
BABA   70.00 (-0.88%)
T   16.07 (-1.05%)
F   12.19 (-0.33%)
MU   121.40 (+0.02%)
GE   155.60 (+1.24%)
CGC   6.89 (-1.29%)
DIS   114.10 (+1.02%)
AMC   2.73 (+10.53%)
PFE   25.86 (-0.19%)
PYPL   63.99 (+0.76%)
XOM   118.92 (-0.64%)
QQQ   432.22 (+0.27%)
AAPL   169.35 (-1.93%)
MSFT   416.39 (+0.66%)
META   502.86 (+0.53%)
GOOGL   154.69 (-0.11%)
AMZN   184.02 (+0.22%)
TSLA   157.92 (-2.20%)
NVDA   875.30 (+1.78%)
AMD   163.71 (+2.11%)
NIO   3.84 (-1.29%)
BABA   70.00 (-0.88%)
T   16.07 (-1.05%)
F   12.19 (-0.33%)
MU   121.40 (+0.02%)
GE   155.60 (+1.24%)
CGC   6.89 (-1.29%)
DIS   114.10 (+1.02%)
AMC   2.73 (+10.53%)
PFE   25.86 (-0.19%)
PYPL   63.99 (+0.76%)
XOM   118.92 (-0.64%)
QQQ   432.22 (+0.27%)
AAPL   169.35 (-1.93%)
MSFT   416.39 (+0.66%)
META   502.86 (+0.53%)
GOOGL   154.69 (-0.11%)
AMZN   184.02 (+0.22%)
TSLA   157.92 (-2.20%)
NVDA   875.30 (+1.78%)
AMD   163.71 (+2.11%)
NIO   3.84 (-1.29%)
BABA   70.00 (-0.88%)
T   16.07 (-1.05%)
F   12.19 (-0.33%)
MU   121.40 (+0.02%)
GE   155.60 (+1.24%)
CGC   6.89 (-1.29%)
DIS   114.10 (+1.02%)
AMC   2.73 (+10.53%)
PFE   25.86 (-0.19%)
PYPL   63.99 (+0.76%)
XOM   118.92 (-0.64%)
QQQ   432.22 (+0.27%)
AAPL   169.35 (-1.93%)
MSFT   416.39 (+0.66%)
META   502.86 (+0.53%)
GOOGL   154.69 (-0.11%)
AMZN   184.02 (+0.22%)
TSLA   157.92 (-2.20%)
NVDA   875.30 (+1.78%)
AMD   163.71 (+2.11%)
NIO   3.84 (-1.29%)
BABA   70.00 (-0.88%)
T   16.07 (-1.05%)
F   12.19 (-0.33%)
MU   121.40 (+0.02%)
GE   155.60 (+1.24%)
CGC   6.89 (-1.29%)
DIS   114.10 (+1.02%)
AMC   2.73 (+10.53%)
PFE   25.86 (-0.19%)
PYPL   63.99 (+0.76%)
XOM   118.92 (-0.64%)
NASDAQ:NH

NantHealth (NH) Stock Price, News & Analysis

$0.34
-0.32 (-48.48%)
(As of 04/15/2024 ET)
Today's Range
$0.34
$0.34
50-Day Range
$0.25
$0.69
52-Week Range
$1.24
$9.75
Volume
638 shs
Average Volume
38,073 shs
Market Capitalization
$2.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NH stock logo

About NantHealth Stock (NASDAQ:NH)

NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.

NH Stock Price History

NH Stock News Headlines

NantHealth (NASDAQ:NH) Now Covered by StockNews.com
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
Best New Hampshire High Schools
See More Headlines
Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Data processing & preparation
Sub-Industry
N/A
Fax
N/A
Employees
326
Year Founded
N/A

Profitability

Net Income
$-67,780,000.00
Pretax Margin
-95.06%

Debt

Sales & Book Value

Annual Sales
$67.68 million
Book Value
($30.72) per share

Miscellaneous

Free Float
2,981,000
Market Cap
$2.62 million
Optionable
Not Optionable
Beta
1.82
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives


NH Stock Analysis - Frequently Asked Questions

How have NH shares performed in 2024?

NantHealth's stock was trading at $0.43 at the start of the year. Since then, NH shares have decreased by 20.9% and is now trading at $0.34.
View the best growth stocks for 2024 here
.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by $0.02. The company earned $14.36 million during the quarter, compared to analyst estimates of $17.70 million. During the same quarter in the previous year, the business posted ($0.08) earnings per share.

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

NantHealth (NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NH) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners